Skip to content

A Study To Evaluate The Safety And Feasibility Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention

A Study To Evaluate The Safety And Feasibility Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention - Safety And Feasibility Of PICSO

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34428
Enrollment
10
Registered
2010-10-04
Start date
2010-07-10
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease Coronary Atherosclerosis

Interventions

Patients will be treated with PICSO. This treatment exists of PICSO catheter placement in the coronary sinus through a femoral vein approach by using a 12F steerable guiding catheter. During two sho

Sponsors

Miracor medical systems
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Subjects at least 18 years of Age - Stable patient - Left Anterior Descending (LAD) Stenosis as assessed by angiography - Able to understand content of and willing to provide written informed consent

Exclusion criteria

Exclusion criteria: - Active and/or treated malignancies within 12 months prior to first Visit - Anatomical Complications (e.g. The system is not able to effectively occlude the coronary sinus) - Presence of significant collateral flow supplying the target vessel (Rentrop 2,3) - Any significant systemic illness or medical condition that could lead to difficulty complying with the protocol; or any concurrent condition(s) which, in the investigator's opinion, would prohibit the subject from completing the study, or in which case the study would not be in the best interest of the subject. - Bleeding or perforation during PCI, pericardial effusion and/or hematoma - Cardiac arrest or arrythmia requiring chest compressions or cardiopulmonary resuscitation - Cardiogenic shock (Cardiac index 2), or hemodynamic instability as assessed by the investigator at the time of cardiac catheterization. - Clinically significant renal disturbance (sMDRD calculated GFR *30mL/min/1,73m²) - Coronary Sinus electrode in place - Acute ST elevation myocardial infarction - Previous Q-wave myocardial infarction within 72 hours prior to screening - Ejection Fraction grade I - mitral stenosis - Patient not currently in sinus rythm - patients on cardiac resynchronization therapy (CRT) or scheduled for CRT implantation - Patients with previous CABG or planned chronic total occlusion revascularization - Pregnancy or active breast-feeding. Urine pregnancy tests will be performed on all women who are not post-menopausal for at least 1 year. - registration in another interventional study - severe anemia at baseline (hemoglobin

Design outcomes

Primary

MeasureTime frame
1. Duration from successful femoral vein cannulation untill successful placement of PICSO Impulse catheter into the Coronary Sinus. 2. Relative increase in collateral flow pressure index (CFpI) during LAD occlusion with and without PICSO.

Secondary

MeasureTime frame
1. Number of patients reaching collateral flow pressure index (CFpI) higher than 30% during PICSO. 2. Quantitative evaluation of pre-condition effect on relative increase of CFpI. 3. The change of ST segment as recorded at Intra coronary ECG measures during balloon inflation

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)